Arthrex Launches 1st and Only FDA-Cleared Kit for the Primary Repair of Anterior Cruciate Ligament Tears

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

December 18, 2020

Arthrex, a global leader in minimally invasive orthopedic technology, announced today the launch of the SwiveLock® ACL Repair Kit, following clearance by the U.S. Food and Drug Administration of the SwiveLock® anchor for ACL repair. It is the first and only FDA-cleared kit for the primary repair of anterior cruciate ligament (ACL) tears.

Arthrex is defining the future for ACL treatment as the first orthopedic company to develop and market a kit specifically for ACL repair,” said President and Founder Reinhold Schmieding. “This is a significant achievement in orthopedic surgery and another testament to Arthrex’s continuous innovation and dedication to its mission of Helping Surgeons Treat Their Patients Better™.”

ACL primary repair with the SwiveLock® ACL Repair Kit involves reattaching a torn ACL utilizing SwiveLock® anchors and high-strength FiberWire® and TigerWire® sutures. The repair utilizes an InternalBrace™ ligament augmentation, which enables patients to return to activity more quickly1 while protecting the repaired ligament. The kit is convenient and contains all the surgical products needed for the ACL repair technique.

Traditional treatment for most ACL tears involves a surgical reconstruction technique, in which graft tissue from the patient’s body or donor tissue is used to recreate the damaged ligament. What a patient receives – reconstruction or repair – is determined by numerous criteria, such as what portion of the ACL is torn, the quality of the remaining ACL tissue, the patient’s goals and activity level, and the acuteness from the initial injury. The kit is indicated for use in proximal ACL tears (tears off the femur), which results in roughly 16 percent of all ACL tears2.

“ACL primary repair offers a fully arthroscopic, more minimally invasive and patient-friendly surgical option for certain types of tears when compared to traditional reconstruction techniques,” said Arthrex Vice President of Strategic Development Larry Higgins, M.D. “Arthrex innovations in technology and techniques have significantly improved outcomes since the origination of this procedure 50 years ago and now provides surgeons the potential to restore a patient’s native anatomy and proprioception. These advancements may allow for a quicker return to activity and diminish pain following the procedure. While primary ‘repair’ will not replace reconstruction for all cases, the procedure, utilizing the SwiveLock® ACL Repair Kit, is a valuable tool to help surgeons treat their patients better.”

The first ACL primary repair with the new kit was completed on November 23, 2020 by Gregory DiFelice, M.D, an orthopedic surgeon at The Hospital for Special Surgery in New York who pioneered this technique and developed this kit in partnership with Arthrex.

“I am very excited about the release of the SwiveLock® ACL Repair Kit. I have been performing ACL primary repair using this technique for more than a decade now and we have developed this kit so that surgeons have all the tools necessary to make this procedure seamless,” he said.

Arthrex has been involved in developing the ACL primary repair procedure since 1983 with the goal of helping patients maintain their native tissue while returning to activity more quickly. In developing this technique and kit, the company has thoroughly studied the procedure and associated patient outcomes in peer reviewed literature3,4,5,6 as well as Arthrex’s Surgical Outcomes System™ (SOS), an orthopedic and sports medicine global registry that tracks patient outcomes following common orthopedic and sports medicine medical procedures across the U.S.

 

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.